• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猕猴长期非进展者抵抗猴免疫缺陷病毒的多个 CD8+ T 细胞逃逸变异体的超感染。

Macaque long-term nonprogressors resist superinfection with multiple CD8+ T cell escape variants of simian immunodeficiency virus.

机构信息

Department of Pathobiological Sciences, University of Wisconsin School of Veterinary Medicine, Madison, Wisconsin 53706, USA.

出版信息

J Virol. 2011 Jan;85(1):530-41. doi: 10.1128/JVI.01025-10. Epub 2010 Oct 20.

DOI:10.1128/JVI.01025-10
PMID:20962091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3014170/
Abstract

Human immunodeficiency virus (HIV)-positive individuals can be superinfected with different virus strains. Individuals who control an initial HIV infection are therefore still at risk for subsequent infection with divergent viruses, but the barriers to such superinfection remain unclear. Here we tested long-term nonprogressors' (LTNPs') susceptibility to superinfection using Indian rhesus macaques that express the major histocompatibility complex class I (MHC-I) allele Mamu-B 17, which is associated with control of the pathogenic AIDS virus SIVmac239. The Mamu-B 17-restricted CD8(+) T cell repertoire is focused almost entirely on 5 epitopes. We engineered a series of SIVmac239 variants bearing mutations in 3, 4, or all 5 of these epitopes and used them to serially challenge 2 Mamu-B 17-positive LTNPs. None of the escape variants caused breakthrough replication in LTNPs, although they readily infected Mamu-B 17-negative naive macaques. In vitro competing coculture assays and examination of viral evolution in hosts lacking Mamu-B 17 suggested that the mutant viruses had negligible defects in replicative fitness. Both LTNPs maintained robust immune responses, including simian immunodeficiency virus (SIV)-specific CD8(+) and CD4(+) T cells and neutralizing antibodies. Our results suggest that escape mutations in epitopes bound by "protective" MHC-I molecules may not be sufficient to establish superinfection in LTNPs.

摘要

人类免疫缺陷病毒 (HIV) 阳性个体可能会被不同的病毒株再次感染。因此,控制初始 HIV 感染的个体仍有随后感染不同病毒的风险,但这种再次感染的障碍尚不清楚。在这里,我们使用表达主要组织相容性复合体 I 类 (MHC-I) 等位基因 Mamu-B 17 的印度猕猴来测试长期非进展者 (LTNPs) 对再次感染的易感性,Mamu-B 17 与控制致病性艾滋病病毒 SIVmac239 有关。Mamu-B 17 限制的 CD8(+) T 细胞库几乎完全集中在 5 个表位上。我们设计了一系列携带 3、4 或全部 5 个表位突变的 SIVmac239 变体,并使用它们对 2 名 Mamu-B 17 阳性 LTNPs 进行了连续挑战。尽管这些逃逸变体很容易感染 Mamu-B 17 阴性的幼稚猕猴,但它们在 LTNPs 中均未引起突破性复制。体外竞争共培养试验和缺乏 Mamu-B 17 的宿主中病毒进化的检查表明,突变病毒在复制适应性方面几乎没有缺陷。这两个 LTNPs 都保持了强大的免疫反应,包括针对 SIV 的 CD8(+) 和 CD4(+) T 细胞和中和抗体。我们的结果表明,与“保护性”MHC-I 分子结合的表位中的逃逸突变可能不足以在 LTNPs 中建立再次感染。

相似文献

1
Macaque long-term nonprogressors resist superinfection with multiple CD8+ T cell escape variants of simian immunodeficiency virus.猕猴长期非进展者抵抗猴免疫缺陷病毒的多个 CD8+ T 细胞逃逸变异体的超感染。
J Virol. 2011 Jan;85(1):530-41. doi: 10.1128/JVI.01025-10. Epub 2010 Oct 20.
2
Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.CD8 +免疫显性模式可能会影响Mamu - B*08阳性猕猴自然控制猿猴免疫缺陷病毒SIVmac239复制的能力。
J Virol. 2008 Feb;82(4):1723-38. doi: 10.1128/JVI.02084-07. Epub 2007 Dec 5.
3
Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques.全面的免疫学评估显示,在精英控制者和疾病进展者中,感染猴免疫缺陷病毒且Mamu - B*17呈阳性的恒河猴之间的差异出奇地少。
J Virol. 2008 Jun;82(11):5245-54. doi: 10.1128/JVI.00292-08. Epub 2008 Apr 2.
4
Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.疫苗诱导的猿猴免疫缺陷病毒特异性CD8 + T细胞反应聚焦于单个Nef表位,感染后不久就会选择逃逸变体。
J Virol. 2015 Nov;89(21):10802-20. doi: 10.1128/JVI.01440-15. Epub 2015 Aug 19.
5
The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in Rhesus Macaques.疫苗诱导的 T 细胞反应频率并不预测恒河猴重复经直肠 SIVmac239 挑战后的获得率。
J Virol. 2019 Feb 19;93(5). doi: 10.1128/JVI.01626-18. Print 2019 Mar 1.
6
Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques.感染“逃逸”病毒变体损害了Mamu - B*08阳性猕猴对猿猴免疫缺陷病毒SIVmac239复制的控制。
J Virol. 2009 Nov;83(22):11514-27. doi: 10.1128/JVI.01298-09. Epub 2009 Sep 2.
7
Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.将猪尾猕猴主要组织相容性复合体I类单倍型与猿猴免疫缺陷病毒感染中的细胞毒性T淋巴细胞逃逸突变联系起来。
J Virol. 2014 Dec;88(24):14310-25. doi: 10.1128/JVI.02428-14. Epub 2014 Oct 1.
8
Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?在由高频主要组织相容性复合体I类分子Mamu - A*02结合的两种细胞毒性T淋巴细胞表位之一中逃逸:病毒进化与持续存在的范例?
J Virol. 2002 Nov;76(22):11623-36. doi: 10.1128/jvi.76.22.11623-11636.2002.
9
Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers.在 Mamu-B*00801(+)恒河猴中,CD8(+) T 细胞反应的逃逸将进展者与精英控制器区分开来。
J Immunol. 2012 Apr 1;188(7):3364-70. doi: 10.4049/jimmunol.1102470. Epub 2012 Mar 2.
10
Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.鉴定出17个由高频分子Mamu - A*02限制的新的猿猴免疫缺陷病毒衍生的CD8 + T细胞表位以及潜在的CTL识别逃逸情况。
J Immunol. 2004 Oct 15;173(8):5064-76. doi: 10.4049/jimmunol.173.8.5064.

引用本文的文献

1
Immunological and virological characteristics of human immunodeficiency virus type 1 superinfection: implications in vaccine design.人类免疫缺陷病毒 1 型合并感染的免疫和病毒学特征:对疫苗设计的影响。
Front Med. 2017 Dec;11(4):480-489. doi: 10.1007/s11684-017-0594-8. Epub 2017 Nov 23.
2
Repertoire comparison of the B-cell receptor-encoding loci in humans and rhesus macaques by next-generation sequencing.通过下一代测序技术比较人类和恒河猴 B 细胞受体编码基因座的库。
Clin Transl Immunology. 2016 Jul 22;5(7):e93. doi: 10.1038/cti.2016.42. eCollection 2016 Jul.
3
SIV genome-wide pyrosequencing provides a comprehensive and unbiased view of variation within and outside CD8 T lymphocyte epitopes.SIV 全基因组焦磷酸测序为 CD8 T 淋巴细胞表位内外的变异提供了全面、无偏的视角。
PLoS One. 2012;7(10):e47818. doi: 10.1371/journal.pone.0047818. Epub 2012 Oct 24.
4
Viral fitness: definitions, measurement, and current insights.病毒适应性:定义、测量和当前的认识。
Curr Opin Virol. 2012 Oct;2(5):538-45. doi: 10.1016/j.coviro.2012.07.007. Epub 2012 Sep 15.
5
Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.细胞免疫应答与 HIV-1 再次感染易感性:一项病例对照研究。
AIDS. 2012 Mar 13;26(5):643-6. doi: 10.1097/QAD.0b013e3283509a0b.
6
CD8+ T cell escape mutations in simian immunodeficiency virus SIVmac239 cause fitness defects in vivo, and many revert after transmission.在体内,猴免疫缺陷病毒 SIVmac239 中的 CD8+ T 细胞逃逸突变导致适应性缺陷,许多在传播后发生回复突变。
J Virol. 2011 Dec;85(23):12804-10. doi: 10.1128/JVI.05841-11. Epub 2011 Sep 28.
7
Understanding animal models of elite control: windows on effective immune responses against immunodeficiency viruses.理解精英控制的动物模型:观察有效免疫反应对抗免疫缺陷病毒的窗口。
Curr Opin HIV AIDS. 2011 May;6(3):197-201. doi: 10.1097/COH.0b013e3283453e16.

本文引用的文献

1
HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.HIV+精英控制器的 HIV 特异性 T 细胞活化水平较低,但仍保持强烈的、多功能的 T 细胞应答。
AIDS. 2010 May 15;24(8):1095-105. doi: 10.1097/QAD.0b013e3283377a1e.
2
MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques.MHC 杂合优势在感染猴免疫缺陷病毒的毛里求斯食蟹猕猴中。
Sci Transl Med. 2010 Mar 10;2(22):22ra18. doi: 10.1126/scitranslmed.3000524.
3
In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.体内 CD8+ T 细胞对 SIV 病毒血症的抑制作用不是由 CTL 清除感染细胞引起的。
PLoS Pathog. 2010 Jan 29;6(1):e1000748. doi: 10.1371/journal.ppat.1000748.
4
CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.CD8+ 淋巴细胞可控制 SIVmac239 感染的恒河猴中的病毒复制,而不会减少感染细胞的寿命。
PLoS Pathog. 2010 Jan 29;6(1):e1000747. doi: 10.1371/journal.ppat.1000747.
5
HIV-1 evolution following transmission to an HLA-B*5801-positive patient.HIV-1传播至一名HLA-B*5801阳性患者后的演变情况。
J Infect Dis. 2009 Dec 15;200(12):1820-4. doi: 10.1086/648377.
6
Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L.广谱中和单克隆抗体 2F5 和 4E10 针对人类免疫缺陷病毒 1 型 gp41 膜近端外部区域,可预防猴免疫缺陷病毒 SHIVBa-L 的粘膜攻击。
J Virol. 2010 Feb;84(3):1302-13. doi: 10.1128/JVI.01272-09. Epub 2009 Nov 11.
7
Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques.感染“逃逸”病毒变体损害了Mamu - B*08阳性猕猴对猿猴免疫缺陷病毒SIVmac239复制的控制。
J Virol. 2009 Nov;83(22):11514-27. doi: 10.1128/JVI.01298-09. Epub 2009 Sep 2.
8
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques.低滴度抗体对猕猴低剂量重复黏膜SHIV攻击具有有效的保护作用。
Nat Med. 2009 Aug;15(8):951-4. doi: 10.1038/nm.1974. Epub 2009 Jun 7.
9
Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.与免疫缺陷病毒复制的精英控制相关的两种MHC I类分子,马猴白细胞抗原-B*08和人白细胞抗原-B*2705,结合具有序列相似性的肽段。
J Immunol. 2009 Jun 15;182(12):7763-75. doi: 10.4049/jimmunol.0900111.
10
Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers.广泛中和性人类抗HIV抗体2G12即使在血清中和效价较低时,也能有效保护机体免受黏膜猴-人免疫缺陷病毒攻击。
PLoS Pathog. 2009 May;5(5):e1000433. doi: 10.1371/journal.ppat.1000433. Epub 2009 May 15.